FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

21259311000001109: Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Nov 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2125181000001116 Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2125191000001119 Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71074201000001118 Femoston-conti 0.5mg/2.5mg tablets (Abbott Healthcare Products Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
71074301000001110 Femoston-conti 0.5mg/2.5mg tablets (Abbott Healthcare Products Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
90062401000001112 Femoston-conti 0.5mg/2.5mg tablets (BGP Products Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
102360701000001111 Femoston-conti 0.5mg/2.5mg tablets (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105690201000001114 Femoston-conti 0.5mg/2.5mg tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Is a Estradiol 500micrograms / Dydrogesterone 2.5mg tablets true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Is a Femoston-conti true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x 28 tablets Has AMP True Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start